A new combination of drugs for the nervous system disease multiple sclerosis, which affects up to 85,000 people in Britain, suggests it may be "highly effective" in some cases, a team of German and Greek doctors said. The drugs are immuno-globulins and mitozantrone, a toxic anti-cancer drug.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments